서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 14 of 14

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2005-01	Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa (R), ZD1839) in chemotherapy-resistant non-small cell lung cancer Han, Sae-Won; Hwang, Pil Gyu; Chung, Doo Hyun; Kim, Dong-Wan; Im, Seock-Ah; Kim, Young Tae; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong International Journal of Cancer, Vol.113 No.1, pp.109-115	DOI
2005-07	Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer Kim, Dae-Young; Lee, Keun-Wook; Yun, Tak; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Oncology Reports, Vol.14 No.1, pp.207-211	DOI
2006-06	Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer Lee, Kyung-Hun; Han, Sae-Won; Hwang, Pil Gyu; Oh, Do-Youn; Kim, Dong-Wan; Chung, Doo Hyun; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Japanese Journal of Clinical Oncology, Vol.36 No.6, pp.344-350	DOI
2008-01	Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin Kim, Sun Young; Kim, Hwang Phill; Kim, Yu Jung; Oh, Do Youn; Im, Seock-Ah; Lee, Dongsoon; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue International Journal of Oncology, Vol.32 No.1, pp.89-95	DOI
2008-06	ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer Lee, Kyung-Hun; Min, Hye Sook; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Kim, Young Tae; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Sung, Sook Whan; Kim, Joo Hyun Lung Cancer, Vol.60 No.3, pp.401-407	DOI
2011-06	Clinicopathologic characteristics of patients with stage III/IV (M 0) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization Im, Seock-Ah; Kim, Jin Won; Kim, Jin-Soo; Kim, Min A.; Jordan, Bruce; Pickl, Marlene; Han, Sae-Won; Oh, Do-Youn; Lee, Hyuk Joon; Kim, Tae-You; Kim, Woo Ho; Yang, Han-Kwang; Bang, Yung-Jue Diagnostic Molecular Pathology, Vol.20 No.2, pp.94-100	DOI
2011-07	Prognostic implication of 18F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study Shin, Dong-Yeop; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Cancer Chemotherapy and Pharmacology, Vol.68 No.1, pp.165-175	DOI
2012-04	The Prognostic Significance of HER2 Positivity for Advanced Gastric Cancer Patients Undergoing First-line Modified FOLFOX-6 Regimen Kim, Jin Won; Im, Seock-Ah; Kim, Miso; Cha, Yongjun; Lee, Kyung-Hun; Keam, Bhumsuk; Kim, Min A.; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Anticancer Research, Vol.32 No.4, pp.1547-1553
2012-07	Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer Lim, Kyu-Hyoung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncology, Vol.83 No.2, pp.57-66	DOI
2014-02	A Phase II Study of Bevacizumab, Oxaliplatin, and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer A Prospective, Multicenter Trial of the Korean Cancer Study Group Hong, Yong Sang; Lee, Sung Sook; Kim, Kyu-pyo; Lee, Jae-Lyun; Kang, Yoon-Koo; Shin, Sang Joon; Ahn, Joong Bae; Jung, Kyung Hae; Im, Seock-Ah; Kim, Tae-You; Kim, Jee Hyun; Park, Young Suk; Kim, Tae Won American Journal of Clinical Oncology, Vol.37 No.1, pp.19-23	DOI
2016-01	Phase I study of CKD-516, a novel vascular disrupting agent, in patients with advanced solid tumors Oh, Do-Youn; Kim, Tae-Min; Han, Sae-Won; Shin, Dong-Yeop; Lee, Yun Gyoo; Lee, Keun-Wook; Kim, Jee Hyun; Kim, Tae-You; Jang, In-Jin; Lee, Jong-Seok; Bang, Yung-Jue Cancer Research and Treatment, Vol.48 No.1, pp.28-36	DOI
2017-01	Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment An, Eunkyung; Ock, Chan Young; Kim, Tae You; Lee, Kyung Hun; Han, Se Won; Im, Seock Ah; Kim, Tae Yong; Liao, Wei Li; Cecchi, Fabiola; Blackler, Adele; Thyparambil, Sheeno; Kim, W. H.; Burrows, Jon; Hembrough, Todd; Catenacci, Daniel V.T.; Oh, Do Youn; Bang, Yung–Jue Annals of Oncology, Vol.28 No.1, pp.110-115	DOI
2017-07	Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis Kim, Seongyeong; Min, Ahrum; Lee, Kyung-Hun; Yang, Yaewon; Kim, Tae-Yong; Lim, Jee Min; Park, So Jung; Nam, Hyun-Jin; Kim, Jung Eun; Song, Sang-Hyun; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae-You; Hangauer, David; Lau, Johnson Yiu-Nam; Im, Kyongok; Lee, Dong Soon; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.3, pp.643-655	DOI
2017-07	CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy Lee, Dae-Won; Im, Seock-Ah; Kim, Yu Jung; Yang, Yaewon; Rhee, Jiyoung; Na, Im Ii; Lee, Kyung-Hun; Kim, Tae -Yong; Han, Sae -Won; Choi, In Sil; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae -You; Bang, Yung-Jue Cancer Research and Treatment, Vol.49 No.3, pp.807-815	DOI

1